2
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
29
Breast Neoplasms
28
Brain Neoplasms
21
Neoplasms
16
Glioma
10
Pancreatic Neoplasms
9
Head and Neck Neoplasms
8
Lymphoma
7
Uterine Cervical Neoplasms
6
Urinary Bladder Neoplasms
6
Rectal Neoplasms
6
Glioblastoma
6
Colonic Neoplasms
6
Carcinoma, Hepatocellular
6
Lymphoma, Non-Hodgkin
5
Lung Neoplasms
5
Astrocytoma
5
Triple Negative Breast Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
4
Liver Neoplasms
4
Disease
4
Central Nervous System Neoplasms
4
Stomach Neoplasms
3
Spinal Cord Neoplasms
3
Sarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Esophageal Neoplasms
3
Carcinoma in Situ
3
Retinoblastoma
2
Pathologic Complete Response
2
Interventions
Fluorouracil
67
Radiotherapy
53
Cisplatin
52
Oxaliplatin
47
Leucovorin
37
Paclitaxel
36
Irinotecan
27
Docetaxel
23
Capecitabine
20
Nivolumab
17
Carboplatin
16
pembrolizumab
15
Radiation
15
Neoadjuvant Therapy
15
Surgical Procedures, Operative
12
Cetuximab
12
durvalumab
9
Drug Therapy
9
Biopsy
9
Taxes
8
Folfox protocol
8
Chemotherapy, Adjuvant
8
Trastuzumab
7
Magnetic Resonance Spectroscopy
7
Gefitinib
7
Endoscopy
7
tremelimumab
6
Specimen Handling
6
Endoscopy, Digestive System
6
Ramucirumab
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Adenocarcinoma Of Esophagus
×
Magnetic Resonance Imaging
×
Clear all
NCT03474341
2020-11-16
PRIDE
UMC Utrecht
Unknown
200 enrolled